Size: px
Start display at page:

Download ""

Transcription

1 1

2

3 1962 J.F

4 SG 1 11 SG SG (1989)

5 BSE

6 TÜV Consumer Product Safety Commission - 5 -

7 BGH 1 A B C A C B a b a

8 PCB DDT

9 a a

10 b b a (1997) - 9 -

11 a a b b 2 b 11 b 2

12 1 a a

13 a O A O157 A X1 X Y 7,800 O157 O157 Y 1 Y 4,

14 H H H H H ,124 H H H H ,770 H , H ,495 H H H H ,815 H H H ,700 H ,490 H H H ,407 H H

15 9. H H H H H H H H H ,170 H PL H H H H H ,960 H H H H H H H ,160 H ,350 5,945 H ,096 H H H ,500 H H H H ,470 H ( ) ( ) H ,321 ( ) ( ) H ,719 ( ) ( ) 21. H , H H ,084 H ,855 H

16 24. H ,472 H H H ,533 H < 1> H H H H ,860 H H H H ,440 < 2> 30. H H , H , H H H < 3> 36. H < 4> 8,200 6, H ,380 H , ,200 < 1> 1 < 2> 2 < 3> < 4>

17 b

18 37 5, ,200 3, Y C

19 A v. National Blood Authority All ER 289(QBD). 5 EC

20 3 c d 13 62,

21 2 O157 O157 0 O

22 a a

23 b

24 3 1 1 a 4 O

25

26 26 12 c 2 a b B b 25 1 a

27 b /59/EEC /34

28 BSE

29

30 6 3 PL

31 9 1 (a) ( )

32 11 (b) (c) X A

33 X A Y A 3 19 A A B A A 1 2 B B A B 3 B 2 X Y A A B A A A A A B A A A B A A A

34 A Y X 600 B A A 1 1 Y A 7 73 A X1 Y Y A A A 8 20 A 8 23 A 8 25 A

35 8 36 A X1 A X2 X3 Y A A A Y 2, A Y Y A X1 X2 X3 X4 Y =

36 Y A 3 A

37 (a) (b) PIO-NET (2 ) (c) X Y Y 3 X Y Y X Y 3 X Y 1 X Y Y X 2,500 Y Y Y Y

38 3 Y

39 24 (a) Q&A

40 , (b)

41 (c) WAMNET

42 35 36 (a) (b) 37 (c)

43 3-42 -

44 (a) NBL NBL

45 (b)

46

47

48 EC EC 48 EC EC EC EC VuR2002,

49 51 52 EC EC

50

untitled

untitled 12 20 22 12 24 24 12 20 22 22 23 21 22 24 22 22 1 21 1577 986 62.5 10.7 56.420 3.4 60.8 23 23 20 54.1 24.4 WAMNET 20 40 20 15 20 12 23 6217 1554 10.7 56.4 1 5160 23 23 4 12 22 600 450 20 24 450 1800 50

More information

untitled

untitled 16 1 1 2 2 2 5 7 7 11 IT 13 19 19 51 95 111 16 10 112 16 114 120 121 21 15 124 PIO NET 5,167 85.3% 13.8% 50.2% 11.3% 1 3.1% 11.8% 13.3%5,167 13 7 18 17 1 31 50 10 10 4 13 15 7 16 15 10 23 13 7 18 17

More information

本組よこ_y001-178/本組よこ_庄_P161‐177

本組よこ_y001-178/本組よこ_庄_P161‐177 161 X A X A X A A A X X X X A Y A X A X A B 162 B X X A A A X A A X A A X X A A A X A X A X A X A A A A X X A A Y A Y Y A 163 X Y A Y X A Y A X X A Y X A Y A 164 A X X X A X Y A X A Y X 165 A B B C C B

More information

2

2 2 () BSE 3 17 6 17 63 17 3 25 16 17 18 4 () 20 30 5 6 7 8 9 10 11 12 13 14 () () 15 () 16 17 18 19 () () 20 157 21 22 () () () 23 () 24 25 26 () () 27 () () 28 29 () () () 30 () () 31 () () 32 () 33 34

More information

2

2 1 2 3 4 300000 265806 250240 250846 391 250000 224607 400 220200 408 204429 374 411 200000 469 136581 113682 128592 101381 126738 108355 150000 43778 100000 46632 48999 42818 50887 47201 50000 92978 90191

More information

6 1873 6 6 6 2

6 1873 6 6 6 2 140 2012 12 12 140 140 140 140 140 1 6 1873 6 6 6 2 3 4 6 6 19 10 39 5 140 7 262 24 6 50 140 7 13 =1880 8 40 9 108 31 7 1904 20 140 30 10 39 =1906 3 =1914 11 6 12 20 1945.3.10 16 1941 71 13 B29 10 14 14

More information

WINET情報

WINET情報 WINETCONTENTS 1 2 3 Q&A Q A 4 Q A 5 Q A 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 No. 10. 1. 11. 2. 12. 3. 4. 13. 5. 14. 6. 7. 15. 8. 9. 16. 33 17. 33. 34. 35. 18. 19. 36.

More information

021017部会資料案.PDF

021017部会資料案.PDF 1995 2001 3105 84.4% 572 15.6% 3771 69.3% 1668 30.7% 2001 6 16000 3 1 2001 6 2000 1800 HACCP HACCPHazard Analysis and Critical Control Points NASA Hazard Analysis Critical Control Point HACCP HACCP 7 3

More information

untitled

untitled -1- -2- -3- -4- -5- -6- -7- -8- -9- -10- -11- -12- -13- 1-14- 10 10-15- -16- -17- -18- -19- -20- 16 16 16 41 29 16 80% 12 16 5 2 0 3 HACCP BSE BSE 4 100% 5 HACCP -21- 6 H15 70 H16 150 7 8 9 10 11 12-22-

More information

特許権侵害における差止め

特許権侵害における差止め [*64] 100 (1) (2) (3) (4) (5) (1) 1 8 1998 227 229 2 1 (2) 2 2000 1 7 1996 (3) 1993 (2) (4) (4) 238 2000 (5) (2) 8 19 (1) (4) 235 238 2000 [*65] 1 (1) 63.12.9 1295 121 35% 62.11.25 19 3 434 (6) (7) 2 (6)

More information

BSE Excel

BSE Excel 200 2 200311110 BSE Excel 1 3 11 1 21 2 20 1 26 2203 2 10 1718 485 13 2 2 6 100 371 12 3 100 679 1 12 2 9 1 29 2 10 1 1-1 2 /kg 1-2 3 1-3 2 http://www.maff.go.jp/ 3 Excel 2 15 1 26 2 2 9 16 1 30 2 10 1-4

More information

2004

2004 2004 2 18 400 1 6 30 40 3 2 2004 2 1 3050 15 11 20 12 2 6 40 3 BSE 2 . 1 1 30 43.5 40 74.0 71.8 57.3 35.3 33.0 18.5 30 86.4 2030 6070 31.5 40 50 37.5 3.3 2.2 2030 28.8 1040 20.9 6070 28.8 45.7 1 3 2 3

More information

AVA卵巣癌適正使用改訂 indd

AVA卵巣癌適正使用改訂 indd Q&A P.58 CONTENTS 2 4 5 5 6 1. 6 2. 10 3. 12 4. 14 5. 15 6. 17 7. 19 8. 20 9. 22 10. 23 11. 24 12. 25 13. 26 14. 27 28 28 28 31 32 32 38 1 38 2 39 40 41 44 44 48 50 58 74 74 76 78 80 81 4 5 6 7 Q&A P.66

More information

- 1 -

- 1 - - 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - - 20 - - 21 - - 22 - - 23 - - 24 - - 25 - - 26 - EC NEC - 27 - NEC - 28 - R NEC

More information

untitled

untitled 2004 1/95 2004 2/95 2004 3/95 2004 4/95 2004 5/95 2004 6/95 2004 7/95 2004 8/95 2004 9/95 2004 10/95 2004 11/95 2004 12/95 2004 13/95 2004 14/95 2004 15/95 2004 16/95 2004 17/95 2004 18/95 2004 19/95 2004

More information

untitled

untitled -1 - 72 DVD 34-2 - 49-3 - 45-4 - OIE BSE 56 OIE BSE 39 BSE 71-5 - 20 30 69-6 - 66-7 - 28-8 - 1 43-9 - 38-10 - 58 46-11 - 69 49 48-12 - 43-13 - 76 35-14 - 43 2 37 2 65 68 CM 57-15 - 19 73 70-16 - - 17 -

More information

178 5 I 1 ( ) ( ) 10 3 13 3 1 8891 8 3023 6317 ( 10 1914 7152 ) 16 5 1 ( ) 6 13 3 13 3 8575 3896 8 1715 779 6 (1) 2 7 4 ( 2 ) 13 11 26 12 21 14 11 21

178 5 I 1 ( ) ( ) 10 3 13 3 1 8891 8 3023 6317 ( 10 1914 7152 ) 16 5 1 ( ) 6 13 3 13 3 8575 3896 8 1715 779 6 (1) 2 7 4 ( 2 ) 13 11 26 12 21 14 11 21 I 178 II 180 III ( ) 181 IV 183 V 185 VI 186 178 5 I 1 ( ) ( ) 10 3 13 3 1 8891 8 3023 6317 ( 10 1914 7152 ) 16 5 1 ( ) 6 13 3 13 3 8575 3896 8 1715 779 6 (1) 2 7 4 ( 2 ) 13 11 26 12 21 14 11 21 4 10 (

More information

自転車研究会報告書最終

自転車研究会報告書最終 7 http://ringring-keirin.jp 2 ...9...10...11...12...12...14...14...15...16...16...17...18...19...21...22...23...25...26 3 ...27...29...29...30...32...33...33...35...36...37 4 5 6 7 8 - 9 10 11 12 13 -

More information

untitled

untitled Q&A Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q Q -88- 1 Q 3,000 4,500 3,000 P.110-89- Q 3,000 4,500 3,000 4,500 3-90- 7 21 2,500 4,500 5,000-91- Q 2,500 5,000 2,500 5,000-92- 3,000 4,500 2,500 5,000 2,600

More information

untitled

untitled 32% 51% #8000 () 22 22 22 U U A A

More information

CG-WLCVR300AGN

CG-WLCVR300AGN 1 2 3 4 5 Q&A 2 3 4 5 6 7 8 http://corega.jp/ 9 10 11 12 13 14 15 16 1 17 18 1 19 20 1 21 22 1 23 24 1 25 26 1 27 28 2 29 30 2 31 32 2 1 2 33 1 2 34 2 35 36 2 1 37 2 3 4 38 2 39 1 2 3 40 2 41 42 2 1 2

More information

平成17年度人文・社会科学分野原子力安全基盤研究ワークショップ

平成17年度人文・社会科学分野原子力安全基盤研究ワークショップ 14 1416 (1) (2) (3) (4) (5) (6) (1) (2) (3) (4) 15 16 (5) 20 600 600( 600 = 30 20 20) 17 17 398 39866.3 66.3 (6) 20 20600 600( 600 = 15 40 40) 14 14 482 ( 80.3%) 463 463( 77.2%) 452 ( 75.3%) 15 15 387

More information

1 1.... 3 2.... 3... 3... 3 3.... 3 4.... 4 5.... 5 1... 5 2... 5 3... 5 4... 5 6.... 6 1... 6 2... 6 3... 7 4... 7 5... 7 6... 7 7.... 8 8.... 8 9.... 9 10.... 21 11.... 21... 22 2 1. 5 2. 1995 3. 6 12

More information

1997年11月発行

1997年11月発行 Monthly Report 1 2 5 6 7 9 10 12 13 14 15 16 17 81 24 2004 9 8 9 6 BSE BSE BSE BSE BSE BSE BSE BSE 20 BSE OIE 2 BSE BSE 1 8 4 BSE BSE BSE BSE SRM BSE BSE BSE () BSE 17 2004 7 1,477 2004 7

More information

Œ{Ł¶.JBD

Œ{Ł¶.JBD 50 EC Employment Outlook 1993. 1997 J OECD EC EC Employment Outlook 1993. OJT T R W WW WW W W T= W WRT W W W W W W WW W 12 21 11 n t 1988 19.1 39.9 30.5 1990 27.1 36.4 25.4 1993 31.8 41.5 22.1 1996 18.9

More information

労働政策研究報告書No.59

労働政策研究報告書No.59 EU200410 1999EU EU 199910EU EU 200011 EU EU EU EU 200411 20052010 2005 200510 206 EU EU4 200322EU 2003/86/ECEU EU 15 1321 207 EU 20031125EU 2003/109/EC200423 2006123 EU 10 EU 200210 EU 2001 208 EU EU EU

More information

EP760取扱説明書

EP760取扱説明書 D D D # % ' ) * +, B - B / 1 Q&A B 2 B 5 B 6 Q & A 7 8 $ % & ' B B B ( B B B B B B B B B B B ) B B B A # $ A B B * 1 2 # $ % # B B % $ # $ % + B B 1 B 2 B B B B B B B B B B , B B B - 1 3 2 2 B B B B B

More information

medical product information 74

medical product information 74 73 medical product information medical product information 74 75 medical product information 76 medical product information 77 medical product information 78 medical product information 79 medical product

More information

Microsoft Word environment.doc

Microsoft Word environment.doc M&A 2005 6 24 M&A 1972 1 1 2 30 29 2 3 4 5 6 7 1 H 1972 H 1992 2004 1972 2 17 3 2005 6 24 64 4,965 0,542 19 2007 2,778 2050 http://www.ipss.go.jp/japanese/newest/newesti91.html

More information

untitled

untitled 1946 21 2 27 1964 39 3 1964 39 4 1967 42 9 1968 43 3 1970 45 4 1970 45 4 1980 55 4 1993 5 1 1994 6 5 2005 17 4 2009 3 1977 1980 1979 9 1981 8 1985 4 1986 3 1989 6 2001 1 1989 10 1997 10 1990 11 2004 5

More information

untitled

untitled 26 9 201491 PL PL PL 1 1 2 3 4 1 1 2 3 4 1,000 10 501003 7 5 6 2 10 1 1 10 2 2 1,000 1,000 50100 50100 50100 50 100 5 6 3 4 3 2 1 10 1100 11,000 1 5001,000 150 1,000 1,000 1,000 90 15001,000 15,000 15,000

More information

= /

= / [ ( 3)] 1 System of National Accounts SNA SNA 1993 93SNA 2008SNA 1.1, Gross Domestic Product (GDP) SNA GDP. 1 (Gross Value Added), (1) (2) (3) 1 1 1 1 1 5 100 75 1 20 30 1 100 500 1500 3000 1 500 +1500

More information

untitled

untitled NO.51 2009 10 10 0570-058-669 http://www.i-nouryoku.com/index.html 36 1 NO.51 2009 10 2 NO.51 2009 10 20 9 9 700 7000 20 9~12 14ha ha 48 8 5 JA 5 3 NO.51 2009 10 4 NO.51 2009 10 5 NO.51 2009 10 6 NO.51

More information

再建型倒産手続における将来取得財産に対する担保権の処遇:

再建型倒産手続における将来取得財産に対する担保権の処遇: ABL ABL E-mail: keiko.yamamoto@boj.or.jp / /2010.4 159 1. 1 1 2 3 4 5 6 1 2005 82 2 2005 84 3 ABL Asset Based Lending ABL 2006 3 ABL ABL 2006 4 3 2005 52 53 4 2008 327 2005 368 5 2005 374 1993 15 6 2009

More information

橡食品班論文[1].PDF

橡食品班論文[1].PDF 3 1 3 2 3 2000 BSE = ISO9000 14000 1) HACCP 2) 3) 4 4 5) 2 6) 7) 5 8) 9) 6 1899 2001 10 15 10 60 70 11 7 30 20 20 12 13 14 8 10 1964 1973 9 3 2 1974 EC 24 EC 1974 9 10 15 16 10 11 12 13 14 15 16 17 18

More information

1 1 1 2 2 3 3 4 5 6 6 7 8 8 8 9 10 10 14 16 17 17 18 18 18 23 27 27 27 28 29 29 30 30 31 32 32 33 34 34 35 36 37 38 38

1 1 1 2 2 3 3 4 5 6 6 7 8 8 8 9 10 10 14 16 17 17 18 18 18 23 27 27 27 28 29 29 30 30 31 32 32 33 34 34 35 36 37 38 38 2007 2006 11 29 1 1 1 2 2 3 3 4 5 6 6 7 8 8 8 9 10 10 14 16 17 17 18 18 18 23 27 27 27 28 29 29 30 30 31 32 32 33 34 34 35 36 37 38 38 40 40 40 11 41 41 42 42 43 43 44 45 46 46 47 47 49 50 51 51 52 53

More information

旅行業法の変遷

旅行業法の変遷 IT ,,, IT IT. MTP MTP MTP MTP FIT Air only GIT.....,, http://www.jyh.or.jp/koukai/jigyo.pdf http://www.tcsa.or.jp/about/history.html NBL.. http://kokkai.ndl.go.jp/...... Customers are always right....

More information

最近の金融経済情勢について

最近の金融経済情勢について (2001=100 15 5 30 ( ) 1637 2003 3 1.0 70.9 2004 3 () 0.7 15.0 85.5 977 2003 3 2.6 102.4 2658.7 2004 3 () 1.5 17.4 59.0 660 2003 3 0.8 38.1 2004 3 () 0.2 11.4 152.3 3 Slim Safety Specialty 2003

More information

Microsoft Word - optical.doc

Microsoft Word - optical.doc 1 2 3 CCD () () 4 5 6 7 ) ) 8 9 10 l l l l 10-9 11 12 13 14 15 16 w h f = = W H L f W f h f 6.6 f = = H L 500 2, 000 17 Ec T R Ec = 2 2 4 F ( m + 1) Es a b m = f V m = = L f m = a f f H = C F B( H + f

More information

個人情報保護本文.doc

個人情報保護本文.doc H13- WG ver..0 ECOM 14 3 WG 1...1 2...3 2.1...3 2.1.1...3 2.1. 2...4 2.1.3...4 2.1.4...5 2.1.5...6 2.1.6...6 3...8 3.1...8 3.2...8 3.2.1...8 3.2.2...9 3.3...10 3.3.1...10 3.3.2...11 3.3.3...12 3.3.4...14

More information

訪問看護ステーションにおける安全性及び安定的なサービス提供の確保に関する調査研究事業報告書

訪問看護ステーションにおける安全性及び安定的なサービス提供の確保に関する調査研究事業報告書 1... 1 2... 3 I... 3 II... 3 1.... 3 2....15 3....17 4....19 5....25 6....34 7....38 8....48 9....58 III...70 3...73 I...73 1....73 2....82 II...98 4...99 1....99 2....104 3....106 4....108 5.... 110 6....

More information

2 33,**. + : +/* /++** +/* /++** +/* /++** /** /** F+ +*** F+ +*** / 1*42.,43 /14+,*42 /, , 134,.,43 / 0-41,*42.4, -/41,*43,34,,+4. +

2 33,**. + : +/* /++** +/* /++** +/* /++** /** /** F+ +*** F+ +*** / 1*42.,43 /14+,*42 /, , 134,.,43 / 0-41,*42.4, -/41,*43,34,,+4. + 1 BSE *,**+ 3 BSE,**- +23,2 + +,3 3+,**, * 2 33,**. + : +/* /++** +/* /++** +/* /++** /** /** F+ +*** F+ +*** / 1*42.,43 /14+,*42 /,341 24-14+ 24- +-4, 134,.,43 / 0-41,*42.4, -/41,*43,34,,+4. +/4../42,240

More information

q w e q w e r

q w e q w e r q w e r t q w e q w e r a s d f a qw e d s q we r q f q w er t y q w q w e r t y u i o!0!1 !2!3!4!5 q w q a s d f g h j k a s d f g h j k a s d f g h j a s d f g h j as d a

More information

SYSMAC(C□□H・C200H・C200HS用)コマンドマニュアル

SYSMAC(C□□H・C200H・C200HS用)コマンドマニュアル SYSMAC 2 3 4 5 6 7 " ( ) 8 9 10 11 890 3456789012345 123456789012345678 901234567890123456789 890123456789012345678901 78901234567890123456789012 6789012345678901234567890121 567890123456789012345678901212

More information

- 191 - - 192 - - 193 - 19962000 80a 1 7 13 60-194 - 10 2006 2007 20-195 - 45 1,000-196 - 3 5-197 - - 198 - 9 6 1 DNJ DNJ DNJ DNJ DNJ 2-199 - - 200 - DNJ DNJ DNJ - 201 - - 202 - DNJ DNJ DNJ - 203 - 21-204

More information

花びら型産業への挑戦

花びら型産業への挑戦 NAVIGATION & SOLUTION 1 C O N T E N T S 52 199911 53 1 1 15 348 220 125 73 49 64 92 59 3 6 8 4 6 6 3 1,060 2010 480 355 245 155 145 140 140 80 15 15 14 13 11 10 9 1,800 132 135 120 82 96 76 48 21 12 9

More information

untitled

untitled 5 2009 MAY Public relations OZU 2009 5 Vol.1 C o n t e n t s P3 P2 P6 P10 P14 P16 P18 P20 P22 P24 P26 P28 P32 P34 2 3 4 5 Q Q A Q A Q A Q A Q A Q A Q A Q A A 21 7 6 9 8 10 11 12 13 14 15 2009 ALL JAPAN

More information

第31期中間決算状況および事業戦略のご説明

第31期中間決算状況および事業戦略のご説明 INDEX IR PO S 200 20014 200111 JASDAQ 1,000) 100 ) Copyright 2002 INTAGE Inc. All Rights Reserved. 4 7 6 2001/3 4 5 2002/3 98/3 99/3 00/3 01/3 02/3 98/3 99/3 00/3 01/3 02/3 98/3 99/3 00/3 01/3 02/3 98/3

More information

はじめに

はじめに [ ] 1 2004 2005 2015 2003 2 1970 200 3 1970 200 1 4 2003 1980 322 2005 JT 1980 5 6 BSEO-157 7 8 9 HACCP 2 HACCPHazard Analysis Critical Control Point System 3 10 4 4 11 2001 1960 12 20032005 PR 500 2004/3

More information

2 3 A B 2 NPO

2 3 A B 2 NPO 13 30 13 1 (1) (9) 9 1 2 3 A B 2 NPO 3 3 22 22 4 2 22 22 5 6 3 3 3 22 3 22 4 4-1 6 WG 6 3 7 8 7 7 11 4-5 3 3 2 1 4 2 Yes No 100 1 22 9 22 3 22 22 3 3 2 4-6 1 5 22 72 1 2 72 72 3 72 72 10 72 72 NPO 72 4-6

More information

化学物質の内分泌かく乱作用に関する環境省の今後の対応方針について

化学物質の内分泌かく乱作用に関する環境省の今後の対応方針について ExTEND2005 2005 3 ExTEND2005 Enhanced Tack on Endocrine Disruption 10 (1998 )5 - SPEED'98-12 (2000 )11 2000 11 ( SPEED'98 ) 14 (2002 )8 (WHO)/ (ILO)/ (UNEP) Global Assessment of the State-of-the-Science

More information

1

1 1 2 9 3 4 5 6 7 2 8 9 http://t.pia.jp/ Point Point TOP 10 11 http://apps.microsoft.com/windows/ja-jp/app/49b9d8c8-278d-4ebe-b320-1d81ad07ff36 http://s.pia.jp/pia/ 12 http://t2.pia.jp/info/api.html 13 http://t2.pia.jp/feature/music/musiccomplex/index.html

More information

06†E”RŠœŠÇ‚¾.mcd

06†E”RŠœŠÇ‚¾.mcd CP JSLA Syndicated Loans mandate Arranger Bilateral Loans A Y X 1 X 2 X 3 AX A X Y Y A A X A C A M M A A M C C M A C Y P X A A C Y X Y X 1 X 2 X 3 Y X Y A A X Y X A A A Y X X X X A Y M Y Y Y

More information

2011 10 64

2011 10 64 企 業 不 祥 事 の 構 造 的 要 因 に 関 する 広 報 学 上 の 課 題 2009 1 Leitner, Friedrich 1915 Die Unternehmungsrisiken 1915 risk management 1929 1931 2004 63 2011 10 64 35 1 2 3 1 2 1 18 19 18 19 1 1 18 1756 1758 3 1815 65

More information

機械指令 2006/42/EC への適合のためのガイド (第2版)

機械指令 2006/42/EC への適合のためのガイド (第2版) 2006/42/EC ( 2 ) e 2013 10 1 1 2 2 2 2.1......... 2 2.2........... 2 3 2 3.1................ 3 3.2..... 3 4 3 4.1....... 3 4.1.1 Annex IV 3 4.1.2 Annex IV......... 4 4.2........... 4 4.2.1............

More information

<95DB88E78F8A82CC8EC091D492B28DB F18D908F912E706466>

<95DB88E78F8A82CC8EC091D492B28DB F18D908F912E706466> ... 1... 2... 3... 4... 5... 6... 8... 14... 14... 14... 15... 16... 18 1... 18 2... 19 3... 20... 21... 21 1... 21 2... 23... 25 1... 25 2... 26... 27 1... 27 2... 27 ... 28 1... 28... 29 1... 29 2...

More information

EU 食品安全政策の展開と動向

EU 食品安全政策の展開と動向 EU EU EU 1996 BSE EU EU BSE 1997 24 EU 1997 EU 2000 2002 EU EU EU EU BSE EU 4 2006.9 EU EU 1997 1997 2000 2002 EU HACCP EurepGAP EU 2003 15 EU 1 2004 EU EU EU 2 EU EU EU EU EU 3 EU EU, 2006, p.92. European

More information